Immuneering (IMRX) EBT Margin (2020 - 2022)
Immuneering's (IMRX) quarterly EBT Margin came in at 2988714.95% in Q4 2022, down 298291233.0% year-on-year from N/an in Q4 2021, and down 2852.28% quarter-over-quarter from 101234.04% in Q3 2022.
Immuneering (IMRX) EBT Margin (2020 - 2022) Analysis & Trends
Immuneering's EBT Margin history runs 3 years deep, the most recent figure standing at 2988714.95% for Q4 2022.
- On a quarterly basis, EBT Margin fell 298291233.0% year-over-year to 2988714.95% in Q4 2022; TTM through Sep 2023 was 19339544.84%, a 1932229148.0% decrease from a year earlier, with the FY2022 full-year figure at 15937.29%, down 1431018.0% from the prior year.
- EBT Margin eased to 2988714.95% in Q4 2022 per IMRX's latest filing, from 101234.04% in the prior quarter.
- Across five years, EBT Margin topped out at 646.07% in Q3 2020 and bottomed at 2988714.95% in Q4 2022.
- The 3-year median for EBT Margin is 5802.62% (2021), against an average of 285967.89%.
- Across the five-year window, EBT Margin plunged 221025 bps in 2021 and plunged 298291233 bps in 2022, its largest moves.
- Year by year, EBT Margin stood at 881.43% in 2020, then slumped by 558 bps to 5802.62% in 2021, then plunged by 51406 bps to 2988714.95% in 2022.
- Per Business Quant, the three latest IMRX EBT Margin figures stand at 2988714.95% (Q4 2022), 101234.04% (Q3 2022), and 20525.33% (Q2 2022).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 17.13% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 33.74% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Immuneering | 279.33 Mn | 279.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -2,988,714.95% |
| Sep 30, 2022 | -101,234.04% |
| Jun 30, 2022 | -20,525.33% |
| Mar 31, 2022 | -9,843.60% |
| Dec 31, 2021 | -5,802.62% |
| Sep 30, 2021 | -13,453.07% |
| Jun 30, 2021 | -2,959.81% |
| Mar 31, 2021 | -836.32% |
| Dec 31, 2020 | -881.43% |
| Sep 30, 2020 | -646.07% |
| Jun 30, 2020 | -749.56% |